Literature DB >> 22368034

Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal cognitive assessment.

Cláudia M Memória1, Mônica S Yassuda, Eduardo Y Nakano, Orestes V Forlenza.   

Abstract

BACKGROUND: The Montreal Cognitive Assessment (MoCA) is a brief cognitive schedule that has been developed for the screening of patients with Mild Cognitive Impairment (MCI). MCI is recognized as a high-risk state for Alzheimer's disease. The aim of the present study is to examine the reliability and validity of the Brazilian version of the MoCA test (MoCA-BR) in a sample of older individuals with at least 4 years of education.
METHODS: The MoCA-BR was administered to 112 older adults who were classified into three diagnostic groups according to their cognitive state (Alzheimer's disease, n = 28; MCI, n = 43; normal controls, n = 41). This procedure was based on clinical and neuropsychological data. The performance in the MoCA-BR was compared with the Mini-mental state examination (MMSE) and the Cambridge Cognitive Examination. Diagnostic accuracy was examined with the receiver operating characteristic (ROC) curve analyses.
RESULTS: Cronbach's alpha for the MoCA-BR was 0.75. Temporal stability (retesting after 3 months) using intraclass correlation coefficient was 0.75 (p < 0.001). The sensitivity and specificity of the MoCA-BR for MCI were 81% and 77%, respectively, with a cut-off score of 25 points. The area under the ROC curve for predicting MCI was 0.82 ± 0.06.
CONCLUSIONS: The present results indicate that the MoCA-BR maintains its core diagnostic properties rendering it a valid and reliable tool for the screening of MCI among older individuals with at least 4 years of education.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22368034     DOI: 10.1002/gps.3787

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  32 in total

1.  Cerebellar Gray Matter Alterations in Huntington Disease: A Voxel-Based Morphometry Study.

Authors:  Paula C de Azevedo; Rachel P Guimarães; Camila C Piccinin; Luiza G Piovesana; Lidiane S Campos; Juliana R Zuiani; Eliza M Tamashiro; Giordanna Pinheiro; Augusto C Amato-Filho; Fernando Cendes; Iscia Lopes-Cendes; Anelyssa D'Abreu
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

2.  Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C.

Authors:  Sérgio Monteiro de Almeida; Clea E Ribeiro; Indianara Rotta; Mauro Piovesan; Bin Tang; Florin Vaida; Sonia Mara Raboni; Scott Letendre; Michael Potter; Meire S Batistela Fernandes; Ronald J Ellis
Journal:  J Neurovirol       Date:  2017-10-23       Impact factor: 2.643

3.  The Brazilian version of the Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity in dementia.

Authors:  Florindo Stella; Orestes Vicente Forlenza; Jerson Laks; Larissa Pires de Andrade; Michelle A Ljubetic Avendaño; Elisandra Villela Gasparetto Sé; João de Castilho Cação; Constantine G Lyketsos; Kate de Medeiros
Journal:  Int Psychogeriatr       Date:  2013-06-14       Impact factor: 3.878

4.  Case Report: Cognitive Impairment without Clinical Spinal Disease May Be the First Sign of HTLV-1 Neurological Alteration.

Authors:  Aline Rejane Rosa de Castro; Ludimila Labanca; Luciana Macedo de Resende; Denise Utsch-Gonçalves
Journal:  Am J Trop Med Hyg       Date:  2020-02       Impact factor: 2.345

5.  CSF Aβ1-42, but not p-Tau181, Predicted Progression from Amnestic MCI to Alzheimer's Disease Dementia.

Authors:  Liara Rizzi; Luciane Missiaggia; Matheus Roriz-Cruz
Journal:  Neuromolecular Med       Date:  2018-10-10       Impact factor: 3.843

6.  Cognitive impairment in patients with psoriatic arthritis.

Authors:  Leonardo Ogawara Kawamoto Lahoz Garcia; Armando Takao Suehiro Júnior; Deusimar Cristian Dos Santos Gómez; Gabriel Seiji Sato Yoshikawa; Caio Kumassaka Kamikoga; Bruno Kusznir Vitturi
Journal:  Acta Neurol Belg       Date:  2021-03-13       Impact factor: 2.396

7.  The influence of education on Chinese version of Montreal cognitive assessment in detecting amnesic mild cognitive impairment among older people in a Beijing rural community.

Authors:  Shu'aijun Zhou; Jianzhong Zhu; Na Zhang; Bailing Wang; Tao Li; Xiaozhen Lv; Tze Pin Ng; Xin Yu; Huali Wang
Journal:  ScientificWorldJournal       Date:  2014-05-28

Review 8.  Physiotherapy for human T-lymphotropic virus 1-associated myelopathy: review of the literature and future perspectives.

Authors:  Katia N Sá; Maíra C Macêdo; Rosana P Andrade; Selena D Mendes; José V Martins; Abrahão F Baptista
Journal:  J Multidiscip Healthc       Date:  2015-02-23

9.  Hypertension and frailty in older adults.

Authors:  Ivan Aprahamian; Eduardo Sassaki; Marília F Dos Santos; Rafael Izbicki; Rafael C Pulgrossi; Marina M Biella; Ana Camila N Borges; Marcela M Sassaki; Leonardo M Torres; Ícaro S Fernandez; Olívia A Pião; Paula L M Castro; Pedro A Fontenele; Mônica S Yassuda
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-11-05       Impact factor: 3.738

10.  Higher arterial stiffness is associated with lower cognitive performance in patients with hypertension.

Authors:  Henrique C S Muela; Valeria A Costa-Hong; Mônica S Yassuda; Natália C Moraes; Claudia M Memória; Michel F Machado; Edson Bor-Seng-Shu; Ricardo C Nogueira; Alfredo J Mansur; Ayrton R Massaro; Ricardo Nitrini; Thiago A Macedo; Luiz A Bortolotto
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-11-05       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.